Effectiveness of the 4-mg Dose of Nicotine Polacrilex for the Initial Treatment of High-Dependent Smokers

Archives of Internal Medicine

Volumn 155, Issue 18, 1995, Pages 1973-1980

  Sachs, David P L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE GUM; PLACEBO;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ADULT; COUNSELING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PATIENT COMPLIANCE; POLYMETHACRYLIC ACIDS; POLYVINYLS; PRIMARY HEALTH CARE; SMOKING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029165303     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1995.00430180077009     Document Type: Article

References (34)

1. These references are listed in order of primary data.
2. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3:235-241.
3. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med. 1989;12:159-182.
4. National Health Interview Survey: Vital and Health Statistics of the National Center for Health Statistics, Advance Data No. 126. Washington, DC: Dept of Health and Human Services; 1986.
5. Hajek P, Jackson P, Belcher M. Long-term use of nicotine chewing gum. JAMA. 1988;260:1593-1596.
6. Killen JD, Fortman SP, Telch MJ, Newman B. Are heavy smokers different from light smokers? a comparison after 48 hours without cigarettes. JAMA. 1988; 260:1581-1585.
7. Tønnesen P, Fryd V, Hansen M, et al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med. 1988;318:15-18.
8. Sachs DPL, Säwe U, Leischow SL. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med. 1993;153:1881-1890.
9. Hughes JR. Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies, and suggestions for future research. J Consult Clin Psychol. 1993;61:751-760.
10. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. Predictors of smoking relapse among self-quitters: a report from the normative aging study. Addict Behav. 1992;17:367-377.
11. Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol. 1992;11:331-334.
12. Puska P, Björkqvist S, Koskela K. Nicotine-containing chewing gum in smoking cessation: a double blind trial with half year follow-up. Addict Behav. 1979; 4:141-146.
13. Kornitzer M, Kittel F, Dramaix M, Bourdoux P. A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting. J Psychom Res. 1987;31:171-176.
14. Tønnesen P, Fryd V, Hansen M, et al. Two and four mg nicotine chewing gum and group counseling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up. Addict Behav. 1988;13:17-27.
15. Blöndal T. Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med. 1989;149:1818-1821.
16. Hughes JR, Gust SW, Keenan RM, Fenwick JW. Effect of dose on nicotine's reinforcing, withdrawal-supression and self-reported effects. J Pharmacol Exp Ther. 1990;252:1175-1183.
17. Campbell IA, Prescott RJ, Tjeder-Burton SM. Smoking cesstion in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med. 1991;85:155-157.
18. Fortmann SP, Killen JD, Telch MJ, Newman B. Minimal contact treatment for smoking cessation. JAMA. 1988;260:1575-1580.
19. Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol. 1990;58:85-92.
20. Jarvis MJ, Raw M, Russell MAH, Feyerabend C. Randomized controlled trial of nicotine chewing-gum. BMJ. 1982;285:537-540.
21. Fagerström KO. Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation. Prev Med. 1984;13:517-527.
22. Henningfield JE, Radzius A, Cooper TM, Clayton RR. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA. 1990;264:1560-1564.
23. Sachs DPL. Nicotine polacrilex: practical use requirements. Curr Pulmonol. 1989; 10:141-158.
24. American Lung Association. Freedom From Smoking for You and Your Family. New York, NY: American Lung Association; 1987.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc. 1958;53:457-481.
26. Sachs DPL. Advances in smoking cessation treatment. Curr Pulmonol. 1991; 12:139-198.
27. Sachs DPL, Säwe U, Leischow SJ. Nicotine transdermal patch, smoking cessation, and gender. In: Harris LS, ed. Problems of Drug Dependence 1991: Proceedings of the 53rd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc: NIDA Research Monograph 119. Washington, DC: US Dept of Health and Human Services, Public Health Service; 1992:367. DHHS publication (ADM) 92-1888.
28. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch? JAMA. 1994;271:589-594.
29. Orleans CT, Resch N, Noll E, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at ‘real-world’ patch users. JAMA. 1994;271:601-607.
30. The Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133-3138.
31. Sachs DPL. Use and efficacy of nicotine patches. J Smoking-Related Dis. 1994; 5(suppl 1):183-193.
32. Benowitz NL. The use of biologic fluid samples in assessing tobacco smoke consumption. In: Grabowski J, Bell CS, eds. Measurement in the Analysis and Treatment of Smoking Behavior: NIDA Research Monograph 48. Rockville, Md: Dept of Health and Human Services, Public Health Service; 1983:6-26.
33. Leischow SJ, Sachs DPL, Hansen MD, Bostrom AG. Nicotine polacrilex placebo and treatment doses: pharmacologic and sensory effects. Psychopharmacology. 1995;117:125-129.
34. Fagerström KO, Schneider NG, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology. 1993;111:271-277.